Skip to main content

The Business of Selling Hope Part II: Direct-to-Consumer Cancer Center Advertising




The majority of cancer patients with incurable stage IV lung or colon cancer think that the chemotherapy they are receiving might cure them.  This was the finding of a study that we discussed in a previous GeriPal post.  Much was discussed about the failure of prognosis communication and the potential role that denial played in the outcome of this study.  But open up a magazine or turn on the TV and you find some other force at play, one that is in the business of selling hope and fear.  One that is best summed up by the following quote from a cancer center advertisement:
“My doctor back home gave me ONLY a few weeks to live. That's when I made the ONE decision that saved my life. I went to [X cancer center]. That was seven years ago. And counting”
We have written about potentially deceptive cancer center advertisments like this in the past, but a recent Annals of Internal Medicine article for the first time helps quantify the practices that these centers are using to bring in patients and referrals.  The authors set out to characterize the informational and emotional content of direct-to-consumer cancer center advertisements. They looked at local and national advertisements in the top 269 U.S. consumer magazines and on 44 television networks in 2012 to evaluate:
  • What types of clinical services these cancer centers promoted to consumers, including whether supportive services were address (including nutritional services, complementary and alternative therapies, spiritual services, psychosocial services, physical or occupational therapy, and palliative care).
  • Whether they addressed the risks, benefits, costs, and insurance availability when discussing clinical services.
  • Whether they used an emotional appeals in their advertising.
  • Whether they used patient testimonials.

What they found

The authors found in their sample that 102 cancer centers included the following content in their direct-to-consumer advertising:
  • Types of clinical services promoted
    • It probably comes at no big surprise that treatments are most often promoted (88%) compared to screening screening (18%) or supportive services (13%). Sadly, only 2% of advertisements mentioned palliative care or symptom management services (e.g. “pain management”)
  • The amount of information provided about these clinical services
    • Again, not a big surprise here either. Benefits of advertised therapies were described a whole lot more than risks (27% vs. 2%). Importantly though, when benefits were described, they were rarely quantified (2%), and no advertisements quantified risks. It was only the rare cancer center advertisement that mentioned coverage or costs (5%), and none mentioned specific insurance plans.
  • The use of emotional advertising appeals 
    • Emotional appeals ruled the day (81% of adverts). The majority (61%) used language that evoked hope (i.e. “your last hope”). 41% of adverts used used fighting or battle language (“I fought, I won.”). 30% evoked fear (“I didn't know if anyone survived pancreatic cancer.”) On the bright side though as I thought it would be much worse, slightly less than a third discussed patient comfort, compassion, symptom management, or quality of life
  • Patient testimonials 
    • Nearly one half of advertisements included patient testimonials, which were usually focused on survival, rarely included disclaimers (15%), and never described the results that a typical patient may expect.

Take Home Point

Cancer centers, even the most prestigious and academic ones, have positioned themselves to be in the business of selling hope.  If you don't believe this study, just do a quick youtube search for both subtle and not so subtle references that play on both hope and fear:

Cancer Center #1: "I was given three months to live..."


Cancer Center #2: "Good morning cancer, watch your back."


Cancer Center #3: "Your best chance of winning is here"


Cancer Center #4: Man with pancreatic cancer: "The five year survival rate is single digits, and here it is eight years later."



by: Eric Widera (@ewidera)

Comments

Andrew Kamell said…
Excellent point. The emotional appeal, the outside chance, the implications that "our care" is so much better than theirs, the war metaphors, etc., are all very misleading to people who are looking for some other message than what they are hearing from their docs. Tough, as neither group has incentive to change.
As an aside, I do have one suggestion. I never let people get away with talking about "Hope" generically; I always ask "Hope for what?" Hope can be for so many things in addition to cure of cancer/ avoidance of death. In fact, if hope is about not dying, we are all hopeless! thanks again
usman khatri said…
One that is best summed up by the following quote from a cancer center advertisement:cheap maternity dresses evening wear

Popular posts from this blog

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Dying without Dialysis

There is a terrific article in this weeks Journal of Pain and Symptom Management by Fliss Murtagh of King's College in London about the epidemiology of symptoms for patients with advanced renal failure who die without dialysis.  This study is important because while we know that patients with advanced renal failure have a limited life expectancy and the average age of initiation of hemodialysis is increasing, we know little about the alternatives to hemodialysis.  Specifically, we know nothing about symptoms affecting quality of life among patients who elect not to start dialysis (so called "conservative management" - is this the best label?).  This article provides a terrific counterpoint to the article in last years NEJM showing that nursing home residents who initiated hemodialysis tended to die and decline in function (see GeriPal write up here). 

The study authors followed patients with the most advanced form of chronic kidney disease (the new name for renal failu…

Does “compassionate deception” have a place in palliative care?

by: Olivia Gamboa (@Liv_g_g)

There is broad consensus in the medical community that lying to patients is unethical.  However, in the care of patients with dementia, the moral clarity of this approach blurs.  In her recent New Yorker article, “The Memory House,”  Larissa MacFarquhar provides an excellent portrait of the common devices of artifice, omission and outright deception that are frequently deployed in the care of patients with dementia.  She furthermore explores the historical and ethical underpinnings of the various approaches used in disclosing (or not) information to patients living with dementia.

Ms. MacFarquhar introduces the idea of “compassionate deception,” or the concept that withholding truths, or even promoting outright falsehoods, is a reasonable and even ethical choice for those caring for patients with dementia.  To the extent that it helps a person with dementia feel happier and calmer, allowing them to believe in a gentler reality (one in which, say, their spo…